Labcorp, Quidel: Omicron Brings Covid Testing Stocks Back In Focus

Our indicative theme on Covid-19 Testing Stocks – which includes companies that produce or carry out tests for Covid-19 infections - is up by 24% year-to-date, roughly in line with the S&P 500. While we were somewhat cautious about the long-term prospects for Covid-19 testing stocks in 2020...
Read more on "Forbes"